Observational studyFrontiers in immunology2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study.

Jeske van Pamelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.